NCT05485974
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05485974
Title A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors HUYABIO International, LLC.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
California Cancer Associates for Research and Excellence, Inc. (cCare) Encinitas California 92024 United States Details
The Oncology Institute of Hope and Innovation Glendale California 91204 United States Details
The Oncology Institute of Hope and Innovation Long Beach California 90805 United States Details
The Oncology Institute of Hope and Innovation Pasadena California 91105 United States Details
California Cancer Associates for Research and Excellence, Inc. (cCare) San Marcos California 92069 United States Details
The Oncology Institute of Hope and Innovation Santa Ana California 92705 United States Details
Sarcoma Oncology Santa Monica California 90403 United States Details
Innovative Clinical Research Institute (ICRI) Whittier California 90603 United States Details
The Oncology Institute of Hope and Innovation Whittier California 90603 United States Details
BRCR Medical Center Plantation Florida 33322 United States Details
Michigan Center of Medical Research Farmington Hills Michigan 48334 United States Details
Alliance for Multispecialty Research, LLC Kansas City Missouri 64114 United States Details
Gabrail Cancer Center Canton Ohio 44718 United States Details
Pan American Center for Oncology Trials (PanOncology Trials) Rio Piedras Puerto Rico 00935 Puerto Rico Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field